Rapid Communication - Research and Reports in Immunology (2022) Volume 5, Issue 2

Coronavirus vaccine-associated lung immunopathology-what is the centrality.

As an extended number of coronavirus antibodies enter human clinical trials, in expansion to understanding their adequacy in avoiding extreme SARS-CoV-2-related infection, a key result that will be accepting outsized examination will be whether these immunizations contribute to lung immunopathology upon common viral contamination.

Author(s): David Corry

Abstract Full Text PDF